AMANDA STRILECKIS: Open Payments
NPI 1578294633 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 96 payments from 16 companies in 2025. Trend: 2023 $3,212 · 2024 $2,978 · 2025 $1,787
Food & beverage: $1,688Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $812 |
| Janssen Biotech, Inc. | 23 | $275 |
| Amgen Inc. | 8 | $151 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $66 |
| GENZYME CORPORATION | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| ANI Pharmaceuticals, Inc. | 2 | $56 |
| Almatica Pharma LLC | 2 | $49 |
| SOBI, INC | 1 | $43 |
Products named: RINVOQ, SKYRIZI, TREMFYA, SAPHNELO, KEVZARA, OFEV, PURIFIED CORTROPHIN GEL, TERIPARATIDE.
Industry payments across CT — which companies pay providers there.
